Detalles de la búsqueda
1.
Characteristics of patients with axial spondyloarthritis by geographic regions: PROOF multicountry observational study baseline results.
Rheumatology (Oxford)
; 61(8): 3299-3308, 2022 08 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34897381
2.
Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial.
Lancet
; 395(10217): 53-64, 2020 01 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31813637
3.
Continuing versus withdrawing ixekizumab treatment in patients with axial spondyloarthritis who achieved remission: efficacy and safety results from a placebo-controlled, randomised withdrawal study (COAST-Y).
Ann Rheum Dis
; 80(8): 1022-1030, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33958326
4.
Multicentre, randomised, open-label, parallel-group study evaluating the efficacy and safety of ixekizumab versus adalimumab in patients with psoriatic arthritis naïve to biological disease-modifying antirheumatic drug: final results by week 52.
Ann Rheum Dis
; 79(10): 1310-1319, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32660977
5.
Inhibition of radiographic progression in psoriatic arthritis by adalimumab independent of the control of clinical disease activity.
Rheumatology (Oxford)
; 58(6): 1025-1033, 2019 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30608620
6.
Musculoskeletal ultrasonography in routine rheumatology practice: data from Central and Eastern European countries.
Rheumatol Int
; 36(6): 845-54, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26923691
7.
Effects of ixekizumab treatment on structural changes in the sacroiliac joint: MRI assessments at 16 weeks in patients with non-radiographic axial spondyloarthritis.
Lancet Rheumatol
; 4(9): e626-e634, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-38288892
8.
Low Incidence of Inflammatory Bowel Disease Adverse Events in Adalimumab Clinical Trials Across Nine Different Diseases.
Arthritis Care Res (Hoboken)
; 73(2): 289-295, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32100944
9.
Withdrawing Ixekizumab in Patients With Psoriatic Arthritis Who Achieved Minimal Disease Activity: Results From a Randomized, Double-Blind Withdrawal Study.
Arthritis Rheumatol
; 73(9): 1663-1672, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33682378
10.
Predicting adherence to therapy in rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis: a large cross-sectional study.
RMD Open
; 5(1): e000585, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30713716
11.
Impact of adalimumab on clinical outcomes, healthcare resource utilization, and sick leave in patients with ankylosing spondylitis: an observational study from five Central and Eastern European countries.
Drugs Context
; 7: 212556, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30483351
12.
Design of a phase IV randomised, double-blind, placebo-controlled trial assessing the ImPact of Residual Inflammation Detected via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) patients (PREDICTRA).
BMJ Open
; 8(2): e019007, 2018 02 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-29490959
13.
Clinical and MRI remission in patients with nonradiographic axial spondyloarthritis who received long-term open-label adalimumab treatment: 3-year results of the ABILITY-1 trial.
Arthritis Res Ther
; 20(1): 61, 2018 03 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-29587851
14.
Anti-beta 2-glycoprotein I antibodies of IgM class are linked to thrombotic disorders in young women without autoimmune disease.
Immunobiology
; 212(3): 193-9, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17412286
15.
Prediction and benefits of minimal disease activity in patients with psoriatic arthritis and active skin disease in the ADEPT trial.
RMD Open
; 3(1): e000415, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29225916
16.
Effectiveness of adalimumab in the treatment of scalp and nail affection in patients with moderate to severe plaque psoriasis in routine clinical practice.
Acta Dermatovenerol Alp Pannonica Adriat
; 26(1): 11-14, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28352929
17.
Anti-beta(2)-glycoprotein I antibodies in children with atopic dermatitis.
Int Immunol
; 14(7): 823-30, 2002 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-12096042
Resultados
1 -
17
de 17
1
Próxima >
>>